16 research outputs found
Fertility of women aged 15–44 years old, by calendar time period and stratified by individual HIV status for Kisesa.
<p>Fertility of women aged 15–44 years old, by calendar time period and stratified by individual HIV status for Kisesa.</p
Fertility of women aged 15–44 years old, by calendar time period and stratified by individual HIV status for Rakai.
<p>Fertility of women aged 15–44 years old, by calendar time period and stratified by individual HIV status for Rakai.</p
HIV prevalence of women aged 15–49 in Study sites.
<p>HIV prevalence of women aged 15–49 in Study sites.</p
Unadjusted fertility rate ratios by age and ART period comparing positives to negatives.
<p>Unadjusted fertility rate ratios by age and ART period comparing positives to negatives.</p
Fertility Rate Ratio (FRR) for 20–44 year olds comparing ART period with pre ART adjusted for by age and residence.
<p>Fertility Rate Ratio (FRR) for 20–44 year olds comparing ART period with pre ART adjusted for by age and residence.</p
Dates of ART Periods included in the analysis.
<p>Dates of ART Periods included in the analysis.</p
By HIV status: number of times individuals reported using VCT at an earlier sero-survey round, versus number of times VCT was actually used at the earlier round.
<p>By HIV status: number of times individuals reported using VCT at an earlier sero-survey round, versus number of times VCT was actually used at the earlier round.</p
Characteristics of individuals attending both Sero-5 and Sero-6 and factors associated with repeat use of VCT at each round<sup>#.</sup>
<p>#Characteristics and behavioural variables are those reported at Sero-6, unless otherwise stated.</p>*<p>p≤0.05,</p>¶<p>p≤0.1.</p><p>Δ Spouse HIV status and VCT use at Sero-6.</p><p>Ω Frequency of condom use in last 12 months considering three most recent partners.</p
Among those who attended Sero 6, proportions of men (n = 3,131) and women (n = 4,877) using different HCT services.
<p>Among those who attended Sero 6, proportions of men (n = 3,131) and women (n = 4,877) using different HCT services.</p
Number of times HCT was ever used (i.e. at sero-surveys and/or elsewhere) by the end of each sero-survey round by HIV status.
<p>Panel A) men; panel B) women. (NB: HIV status reflects status at the sero-survey round in question, rather than at any earlier test).</p